Heart drug could shield brain after aneurysm rupture
NCT ID NCT05664191
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 35 times
Summary
This study tests whether a drug called levosimendan, usually used for heart failure, can help prevent dangerous brain spasms and delayed damage after a type of bleeding stroke (aneurysmal subarachnoid hemorrhage). About 30 adults in intensive care will receive either the drug or a placebo. The goal is to see if it reduces complications like delayed brain injury or death within 14 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUB-ARACHNOID HAEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Lariboisière, Service d'anesthésie Réanimation
RECRUITINGParis, France, 75010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.